Legion Partners, L.P. II - Insider Non-Derivative Transactions at LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jan 9, 2023, Legion Partners, L.P. II's relationship to LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) is Director, and currently has 5,906 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other LFCR insiders.

Data Source: SEC.
Legion Partners, L.P. II - Insider Non-Derivative Transactions of LFCR Common Stock
Legion Partners, L.P. II - Insider Non-Derivative Transactions at LFCR
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jan 10, 2023 Acquisition -- (Common Stock) 5906 0 5906